Chewing gum for vertigo relief in the emergency room
Part of Brain & nervous system, Ear, nose & throat clinical trials.
This trial tests whether chewing gum helps reduce dizziness in people with a common inner-ear disorder (BPPV) who come to the emergency room. If you are already receiving standard dizziness medicine, chewing gum might make you feel better faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been dizzy for less than 24 hours.
- A doctor has confirmed your dizziness is due to a specific inner-ear problem called posterior canal BPPV.
- You are getting a standard dizziness medicine (dimenhydrinate) through an IV.
- Your dizziness is moderate (rated 4–7 on a 0–10 scale) and you are awake, alert, and able to chew gum.
- You are not pregnant, not actively vomiting, and have no jaw, dental, or gum issues that make chewing hard.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if taking vitamin D and calcium supplements can reduce the number of repeat vertigo episodes in people with BPPV and low vitamin D levels. The treatment is simple and may help you have fewer dizzy spells.
This trial tests whether having a physical therapist see you in the emergency room can help with dizziness. If successful, it could improve care for people with dizziness who go to the ER.
This study is observing patients who come to the emergency department with vertigo, dizziness, or unsteadiness. Researchers want to predict which of these symptoms are caused by a brain problem (central nervous system), helping doctors make fast and accurate decisions.
This study tests whether adding Brandt-Daroff exercises (simple head movements you can do at home) to a standard treatment called GANS maneuver helps reduce dizziness and improve daily life for people with BPPV.
This study tests a medication called rimegepant (a CGRP blocker) as a treatment for sudden dizziness attacks that come with migraine-like symptoms. If you have these kinds of dizzy spells, this trial may help find out if the drug can stop them quickly.
This study tracks people who have brief episodes of vertigo or dizziness that may be caused by temporary reduced blood flow to the back of the brain. The goal is to better understand these episodes and improve diagnosis and treatment.
Hear when a new Dizziness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.